None
None, None [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared (RPHM) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - - Average | - - | - - | - - | - - | |||||||||||||||
| Maximum | - - | - - | - - | - - | |||||||||||||||
| Minimum | - - | - - | - - | - - | |||||||||||||||
| Vir Biotechnology, Inc. VIR | 6.78 | 0.04 0.59% | 1,254 vs. 995 | 933.00 | 56.00 | -65.00 | -111.00 | -303.00 | -0.4800 | -5.2847 | 0.0000 | 0.9188 | -1.1579 | -0.0422 | -0.0364 | 12.4686 | 137.00 | ||
| Royalty Pharma plc RPRX | 26.66 | 0.44 1.66% | 1,454 vs. 2,324 | 11,842.00 | 567.00 | 4.00 | 583.00 | 2,427.00 | 0.0106 | 701.8537 | 0.0070 | -0.0275 | 0.0084 | 0.0007 | 0.0003 | 12.4802 | 444.00 | ||
| Apellis Pharmaceuticals, Inc. APLS | 27.71 | 0.22 0.80% | 634 vs. 2,868 | 3,446.00 | 172.00 | -66.00 | -133.00 | -2,903.00 | -0.5400 | -27.6326 | 0.0000 | 0.8802 | -0.3855 | -0.2491 | -0.0798 | 2.7985 | 124.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.